Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Neus Boto"'
Autor:
Paolo Petazzi, Laia Miquel‐Serra, Sergio Huertas, Cecilia González, Neus Boto, Eduardo Muñiz‐Diaz, Pablo Menéndez, Ana Sevilla, Núria Nogués
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 10, Pp n/a-n/a (2022)
Abstract The limited availability of red cells with extremely rare blood group phenotypes is one of the global challenges in transfusion medicine that has prompted the search for alternative self‐renewable pluripotent cell sources for the in vitro
Externí odkaz:
https://doaj.org/article/527d9914f6c044929821fda67e9a27db
Autor:
Angel F. Remacha, M. Arilla, Imma Moreno, Neus Boto, Adelaida Ramos, Jorge Sierra, Rodrigo Martino, Concepción Pastoret, P Madoz, Clara Martínez, E Muniz-Diaz, C. Canals
Publikováno v:
Transfusion. 44:1603-1611
BACKGROUND: Most studies indicate that ABO incompatibility has no effect on the clinical outcome after allogeneic peripheral blood progenitor cell (PBPC) transplantation (allo-PBPCT). However, it carries additional risks of hemolytic reactions, delay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d764ecf4ddebd8c5e574b139aff2c60
https://doi.org/10.1111/j.1537-2995.2004.04106.x
https://doi.org/10.1111/j.1537-2995.2004.04106.x
Autor:
Fátima, Baía, Eduardo, Muñiz-Diaz, Neus, Boto, Marta, Salgado, Rosa, Montero, Teresa, Ventura, Helena, Sousa, Branca, Alves, Núria, Nogués, Carmen, Koch
Publikováno v:
Blood transfusion = Trasfusione del sangue. 11(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc4a587233b863223d31077fe5cd9b28
https://pubmed.ncbi.nlm.nih.gov/23399363
https://pubmed.ncbi.nlm.nih.gov/23399363
Autor:
Carmen, Canals, Eduardo, Muñiz-Díaz, Clara, Martínez, Rodrigo, Martino, Imma, Moreno, Adelaida, Ramos, Marina, Arilla, Neus, Boto, Concepción, Pastoret, Angel, Remacha, Jorge, Sierra, Pedro, Madoz
Publikováno v:
Transfusion. 44(11)
Most studies indicate that ABO incompatibility has no effect on the clinical outcome after allogeneic peripheral blood progenitor cell (PBPC) transplantation (allo-PBPCT). However, it carries additional risks of hemolytic reactions, delayed red blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eab340d173cc964e23e04e78d5f1c218
https://pubmed.ncbi.nlm.nih.gov/15504166
https://pubmed.ncbi.nlm.nih.gov/15504166